Discover how the experimental drug lepodisiran dramatically lowers lipoprotein(a) levels, potentially transforming treatment ...

A single dose of an experimental drug has been found to reduce the risk of genetic heart disease by at least 94 per cent. Lepodisiran, developed by Eli Lilly, has shown promising results in reducing ...

A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the blood. The drug, made by Eli Lilly and called lepodisiran, lowered ...

The drug's effects lasted six months with no major side effects, according to new research presented in Chicago Sunday at an ...

Eli Lilly’s experimental drug lepodisiran has shown a 94% reduction in lipoprotein(a) levels, a key genetic risk factor for ...

This year, people on Medicare Part D will not have to pay more than $2,000 in out-of-pocket drug expenditures — and that ...

The Queensland pill testing service CheQpoint has detected a third sample of nitazene, a powerful and highly toxic synthetic ...

Some pill cases come with customizable labels (in case you’d rather sort your pills by type instead of day). Traditional pill organizers have individual lids that pop open. While there are ...

A pill used in most U.S. abortions has been ensnared in politics for years, and many Americans wonder whether it will be ...

Hoosiers using test strips to detect the presence of fentanyl or other controlled substances soon no longer will be subject ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $9.38, with a high ...